Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Karen Lu
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Disorders
Concepts & Ideas
Procedures
Chemicals & Drugs
Genes & Molecular Sequences
Physiology
Sign-in to see full Profile
Network (preview)
30
Gershenson, David
20
Broaddus, Russell
20
Slomovitz, Brian
15
Sun, Charlotte
14
Schmeler, Kathleen
13
Soliman, Pamela
10
Bodurka, Diane
9
Daniels, Molly
9
Milam, Michael
9
Wu, Weiguo
8
Schmandt, Rosemarie
8
Liu, Jinsong
8
Bast, Robert
7
Burke, Thomas
7
Deavers, Michael
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Karen Lu (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Lu Karen H; Yates Melinda S; Mok Samuel C
The monkey, the hen, and the mouse: models to advance ovarian cancer chemoprevention.
Cancer prevention research (Philadelphia, Pa.) 2009;2(9):773-5.
-
2009: Daniels Molly S; Urbauer Diana L; Stanley Jennifer L; Johnson Kristin G; Lu Karen H
Timing of BRCA1/BRCA2 genetic testing in women with ovarian cancer.
Genetics in medicine : official journal of the American College of Medical Genetics 2009;11(9):624-8.
-
2009: Tung Celestine S; Mok Samuel C; Tsang Yvonne T M; Zu Zhifei; Song Huijuan; Liu Jinsong; Deavers Michael T; Malpica Anais; Wolf Judith K; Lu Karen H; Gershenson David M; Wong Kwong-Kwok
PAX2 expression in low malignant potential ovarian tumors and low-grade ovarian serous carcinomas.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2009;22(9):1243-50.
-
2009: Samanta Ajoy K; Huang Helen J; Le Xiao-Feng; Mao Weiqun; Lu Karen H; Bast Robert C; Liao Warren S-L
MEKK3 expression correlates with nuclear factor kappa B activity and with expression of antiapoptotic genes in serous ovarian carcinoma.
Cancer 2009;115(17):3897-908.
-
2009: Schmeler Kathleen M; Daniels Molly S; Brandt Amanda C; Lu Karen H
Endometrial cancer in an adolescent: a possible manifestation of Cowden syndrome.
Obstetrics and gynecology 2009;114(2 Pt 2):477-9.
-
2009: Gershenson David M; Sun Charlotte C; Bodurka Diane; Coleman Robert L; Lu Karen H; Sood Anil K; Deavers Michael; Malpica Anais L; Kavanagh John J
Recurrent low-grade serous ovarian carcinoma is relatively chemoresistant.
Gynecologic oncology 2009;114(1):48-52.
-
2009: Lu Karen H
Management of early-stage endometrial cancer.
Seminars in oncology 2009;36(2):137-44.
-
2009: Litton Jennifer K; Westin Shannon N; Ready Kaylene; Sun Charlotte C; Peterson Susan K; Meric-Bernstam Funda; Gonzalez-Angulo Ana M; Bodurka Diane C; Lu Karen H; Hortobagyi Gabriel N; Arun Banu K
Perception of screening and risk reduction surgeries in patients tested for a BRCA deleterious mutation.
Cancer 2009;115(8):1598-604.
-
2009: Zhang Qian; Shen Qi; Celestino Joseph; Milam Michael R; Westin Shannon N; Lacour Robin A; Meyer Larissa A; Shipley Gregory L; Davies Peter J A; Deng Lei; McCampbell Adrienne S; Broaddus Russell R; Lu Karen H
Enhanced estrogen-induced proliferation in obese rat endometrium.
American journal of obstetrics and gynecology 2009;200(2):186.e1-8.
-
2009: Ready Kaylene J; Vogel Kristen J; Atchley Deann P; Broglio Kristine R; Solomon Kimberly K; Amos Christopher; Lu Karen H; Hortobagyi Gabriel N; Arun Banu
Accuracy of the BRCAPRO model among women with bilateral breast cancer.
Cancer 2009;115(4):725-30.
-
2008: Soliman Pamela T; Bassett Roland L; Wilson Erik B; Boyd-Rogers Stephanie; Schmeler Kathleen M; Milam Michael R; Gershenson David M; Lu Karen H
Limited public knowledge of obesity and endometrial cancer risk: what women know.
Obstetrics and gynecology 2008;112(4):835-42.
-
2008: Lacour Robin A; Daniels Molly S; Westin Shannon N; Meyer Larissa A; Burke Catherine C; Burns Kimberly A; Kurian Shiney; Webb Nicki F; Pustilnik Terri B; Lu Karen H
What women with ovarian cancer think and know about genetic testing.
Gynecologic oncology 2008;111(1):132-6.
-
2008: Kwon Janice S; Lu Karen H
Cost-effectiveness analysis of endometrial cancer prevention strategies for obese women.
Obstetrics and gynecology 2008;112(1):56-63.
-
2008: Meyer Larissa A; Westin Shannon N; Lu Karen H; Milam Michael R
Genetic polymorphisms and endometrial cancer risk.
Expert review of anticancer therapy 2008;8(7):1159-67.
-
2008: Kwon Janice S; Sun Charlotte C; Peterson Susan K; White Kristin G; Daniels Molly S; Boyd-Rogers Stephanie G; Lu Karen H
Cost-effectiveness analysis of prevention strategies for gynecologic cancers in Lynch syndrome.
Cancer 2008;113(2):326-35.
-
2008: Schmeler K M; Lu K H
Gynecologic cancers associated with Lynch syndrome/HNPCC.
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2008;10(6):313-7.
-
2008: Lu Karen H; Wu Weiguo; Dave Bhuvanesh; Slomovitz Brian M; Burke Thomas W; Munsell Mark F; Broaddus Russell R; Walker Cheryl Lyn
Loss of tuberous sclerosis complex-2 function and activation of mammalian target of rapamycin signaling in endometrial carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(9):2543-50.
-
2008: Klopp Ann H; Jhingran Anuja; Ramdas Latha; Story Michael D; Broadus Russell R; Lu Karen H; Eifel Patricia J; Buchholz Thomas A
Gene expression changes in cervical squamous cell carcinoma after initiation of chemoradiation and correlation with clinical outcome.
International journal of radiation oncology, biology, physics 2008;71(1):226-36.
-
2008: Feng Weiwei; Marquez Rebecca T; Lu Zhen; Liu Jinsong; Lu Karen H; Issa Jean-Pierre J; Fishman David M; Yu Yinhua; Bast Robert C
Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
Cancer 2008;112(7):1489-502.
-
2008: Wu W; Celestino J; Milam M R; Schmeler K M; Broaddus R R; Ellenson L H; Lu K H
Primary chemoprevention of endometrial hyperplasia with the peroxisome proliferator-activated receptor gamma agonist rosiglitazone in the PTEN heterozygote murine model.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2008;18(2):329-38.
-
2008: Milam M R; Soliman P T; Chung L H; Schmeler K M; Bassett R L; Broaddus R R; Lu K H
Loss of phosphatase and tensin homologue deleted on chromosome 10 and phosphorylation of mammalian target of rapamycin are associated with progesterone refractory endometrial hyperplasia.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2008;18(1):146-51.
-
2008: Lu Karen H
Hereditary gynecologic cancers: differential diagnosis, surveillance, management and surgical prophylaxis.
Familial cancer 2008;7(1):53-8.
-
2007: Lu Karen H; Schorge John O; Rodabaugh Kerry J; Daniels Molly S; Sun Charlotte C; Soliman Pamela T; White Kristin G; Luthra Rajyalakshmi; Gershenson David M; Broaddus Russell R
Prospective determination of prevalence of lynch syndrome in young women with endometrial cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(33):5158-64.
-
2007: Vogel Kristen J; Atchley Deann P; Erlichman Julie; Broglio Kristine R; Ready Kaylene J; Valero Vicente; Amos Christopher I; Hortobagyi Gabriel N; Lu Karen H; Arun Banu
BRCA1 and BRCA2 genetic testing in Hispanic patients: mutation prevalence and evaluation of the BRCAPRO risk assessment model.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(29):4635-41.
-
2007: Wong Kwong-Kwok; Lu Karen H; Malpica Anais; Bodurka Diane C; Shvartsman Hyun S; Schmandt Rosemarie E; Thornton Angela D; Deavers Michael T; Silva Elvio G; Gershenson David M
Significantly greater expression of ER, PR, and ECAD in advanced-stage low-grade ovarian serous carcinoma as revealed by immunohistochemical analysis.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2007;26(4):404-9.
-
2007: Saldivar J Salvador; Lu Karen H; Liang Dong; Gu Jian; Huang Maosheng; Vlastos Anne-Therese; Follen Michele; Wu Xifeng
Moving toward individualized therapy based on NER polymorphisms that predict platinum sensitivity in ovarian cancer patients.
Gynecologic oncology 2007;107(1 Suppl 1):S223-9.
-
2007: Milam Michael R; Gu Jian; Yang Hushan; Celestino Joseph; Wu Weiguo; Horwitz Irwin B; Lacour Robin A; Westin Shannon N; Gershenson David M; Wu Xifeng; Lu Karen H
STK15 F31I polymorphism is associated with increased uterine cancer risk: a pilot study.
Gynecologic oncology 2007;107(1):71-4.
-
2007: Badgwell Donna; Lu Zhen; Cole Laurence; Fritsche Herbert; Atkinson Edward N; Somers Elizabeth; Allard Jeffrey; Moore Richard G; Lu Karen H; Bast Robert C
Urinary mesothelin provides greater sensitivity for early stage ovarian cancer than serum mesothelin, urinary hCG free beta subunit and urinary hCG beta core fragment.
Gynecologic oncology 2007;106(3):490-7.
-
2007: Shvartsman Hyun S; Sun Charlotte C; Bodurka Diane C; Mahajan Vrinda; Crispens Marta; Lu Karen H; Deavers Michael T; Malpica Anais; Silva Elvio G; Gershenson David M
Comparison of the clinical behavior of newly diagnosed stages II-IV low-grade serous carcinoma of the ovary with that of serous ovarian tumors of low malignant potential that recur as low-grade serous carcinoma.
Gynecologic oncology 2007;105(3):625-9.
-
2007: Milam Michael R; Celestino Joseph; Wu Weiguo; Broaddus Russell R; Schmeler Kathleen M; Slomovitz Brian M; Soliman Pamela T; Gershenson David M; Wang Hong; Ellenson Lora H; Lu Karen H
Reduced progression of endometrial hyperplasia with oral mTOR inhibition in the Pten heterozygote murine model.
American journal of obstetrics and gynecology 2007;196(3):247.e1-5.
-
2007: Milam Michael R; Sood Anil K; King Sara; Bassett Roland L; Lu Karen H; Slomovitz Brian M; Coleman Robert L; Ramirez Pedro T
Supracervical hysterectomy in patients with advanced epithelial ovarian cancer.
Obstetrics and gynecology 2007;109(3):641-6.
-
2006: Slomovitz Brian M; Sun Charlotte C; Frumovitz Michael; Soliman Pamela T; Schmeler Kathleen M; Pearson Heidi C; Berenson Abbey; Ramirez Pedro T; Lu Karen H; Bodurka Diane C
Are women ready for the HPV vaccine?
Gynecologic oncology 2006;103(1):151-4.
-
2006: Schmeler Kathleen M; Sun Charlotte C; Bodurka Diane C; White Kristin G; Soliman Pamela T; Uyei Anne R; Erlichman Julie L; Arun Banu K; Daniels Molly S; Rimes Susan A; Peterson Susan K; Slomovitz Brian M; Milam Michael R; Gershenson David M; Lu Karen H
Prophylactic bilateral salpingo-oophorectomy compared with surveillance in women with BRCA mutations.
Obstetrics and gynecology 2006;108(3 Pt 1):515-20.
-
2006: Schmandt Rosemarie E; Bennett Marsha; Clifford Stephanie; Thornton Angela; Jiang Feng; Broaddus Russell R; Sun Charlotte C; Lu Karen H; Sood Anil K; Gershenson David M
The BRK tyrosine kinase is expressed in high-grade serous carcinoma of the ovary.
Cancer biology & therapy 2006;5(9):1136-41.
-
2006: Gershenson David M; Sun Charlotte C; Lu Karen H; Coleman Robert L; Sood Anil K; Malpica Anais; Deavers Michael T; Silva Elvio G; Bodurka Diane C
Clinical behavior of stage II-IV low-grade serous carcinoma of the ovary.
Obstetrics and gynecology 2006;108(2):361-8.
-
2006: Wu W; Slomovitz B M; Soliman P T; Schmeler K M; Celestino J; Milam M R; Lu K H
Correlation of cyclin D1 and cyclin D3 overexpression with the loss of PTEN expression in endometrial carcinoma.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2006;16(4):1668-72.
-
2006: Soliman Pamela T; Wu Diana; Tortolero-Luna Guillermo; Schmeler Kathleen M; Slomovitz Brian M; Bray Molly S; Gershenson David M; Lu Karen H
Association between adiponectin, insulin resistance, and endometrial cancer.
Cancer 2006;106(11):2376-81.
-
2006: Schmeler Kathleen M; Lynch Henry T; Chen Lee-may; Munsell Mark F; Soliman Pamela T; Clark Mary Beth; Daniels Molly S; White Kristin G; Boyd-Rogers Stephanie G; Conrad Peggy G; Yang Kathleen Y; Rubin Mary M; Sun Charlotte C; Slomovitz Brian M; Gershenson David M; Lu Karen H
Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome.
The New England journal of medicine 2006;354(3):261-9.
-
2006: Broaddus Russell R; Lynch Henry T; Chen Lee-May; Daniels Molly S; Conrad Peggy; Munsell Mark F; White Kristin G; Luthra Rajyalakshmi; Lu Karen H
Pathologic features of endometrial carcinoma associated with HNPCC: a comparison with sporadic endometrial carcinoma.
Cancer 2006;106(1):87-94.
-
2006: Broaddus Russell R; Lu Karen H
Women with HNPCC: a target population for the chemoprevention of gynecologic cancers.
Frontiers in bioscience : a journal and virtual library 2006;11():2077-80.
-
2005: Soliman Pamela T; Broaddus Russell R; Schmeler Kathleen M; Daniels Molly S; Gonzalez Delia; Slomovitz Brian M; Gershenson David M; Lu Karen H
Women with synchronous primary cancers of the endometrium and ovary: do they have Lynch syndrome?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(36):9344-50.
-
2005: Rosen Daniel G; Wang Lin; Atkinson J Neeley; Yu Yinhua; Lu Karen H; Diamandis Eleftherios P; Hellstrom Ingegerd; Mok Samuel C; Liu Jinsong; Bast Robert C
Potential markers that complement expression of CA125 in epithelial ovarian cancer.
Gynecologic oncology 2005;99(2):267-77.
-
2005: Schmeler Kathleen M; Soliman Pamela T; Sun Charlotte C; Slomovitz Brian M; Gershenson David M; Lu Karen H
Endometrial cancer in young, normal-weight women.
Gynecologic oncology 2005;99(2):388-92.
-
2005: Marquez Rebecca T; Baggerly Keith A; Patterson Andrea P; Liu Jinsong; Broaddus Russell; Frumovitz Michael; Atkinson Edward N; Smith David I; Hartmann Lynn; Fishman David; Berchuck Andrew; Whitaker Regina; Gershenson David M; Mills Gordon B; Bast Robert C; Lu Karen H
Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(17):6116-26.
-
2005: Eder Astrid M; Sui Xiaomei; Rosen Daniel G; Nolden Laura K; Cheng Kwai Wa; Lahad John P; Kango-Singh Madhuri; Lu Karen H; Warneke Carla L; Atkinson Edward N; Bedrosian Isabelle; Keyomarsi Khandan; Kuo Wen-lin; Gray Joe W; Yin Jerry C P; Liu Jinsong; Halder Georg; Mills Gordon B
Atypical PKCiota contributes to poor prognosis through loss of apical-basal polarity and cyclin E overexpression in ovarian cancer.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(35):12519-24.
-
2005: Liu Zhensheng; Wang Li-E; Wang Luo; Lu Karen H; Mills Gordon B; Bondy Melissa L; Wei Qingyi
Methylation and messenger RNA expression of p15INK4b but not p16INK4a are independent risk factors for ovarian cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(13):4968-76.
-
2005: Lee Christine M; Slomovitz Brian M; Greer Marilyn; Sharma Sheena; Gregurich Mary Ann; Burke Thomas; Lu Karen H; Ramondetta Lois M
Practice patterns of SGO members for stage IIIA endometrial cancer.
Gynecologic oncology 2005;98(1):77-83.
-
2005: Lu Karen H; Gershenson David M
Update on the management of ovarian germ cell tumors.
The Journal of reproductive medicine 2005;50(6):417-25.
-
2005: Caudell Jimmy J; Deavers Michael T; Slomovitz Brian M; Lu Karen H; Broaddus Russell R; Gershenson David M; Ramondetta Lois M
Imatinib mesylate (gleevec)--targeted kinases are expressed in uterine sarcomas.
Applied immunohistochemistry & molecular morphology : AIMM / official publication of the Society for Applied Immunohistochemistry 2005;13(2):167-70.
-
2005: Slomovitz B M; Ramondetta L M; Lee C M; Oh J C; Eifel P J; Jhingran A; Burke T W; Gershenson D M; Lu K H
Heterogeneity of stage IIIA endometrial carcinomas: implications for adjuvant therapy.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2005;15(3):510-6.
-
2005: Soliman Pamela T; Oh Jonathan C; Schmeler Kathleen M; Sun Charlotte C; Slomovitz Brian M; Gershenson David M; Burke Thomas W; Lu Karen H
Risk factors for young premenopausal women with endometrial cancer.
Obstetrics and gynecology 2005;105(3):575-80.
-
2005: Lu Karen H; Dinh Mai; Kohlmann Wendy; Watson Patrice; Green Jane; Syngal Sapna; Bandipalliam Prathap; Chen Lee-May; Allen Brian; Conrad Peggy; Terdiman Jonathan; Sun Charlotte; Daniels Molly; Burke Thomas; Gershenson David M; Lynch Henry; Lynch Patrick; Broaddus Russell R
Gynecologic cancer as a "sentinel cancer" for women with hereditary nonpolyposis colorectal cancer syndrome.
Obstetrics and gynecology 2005;105(3):569-74.
-
2004: Cheng Kwai Wa; Lahad John P; Kuo Wen-Lin; Lapuk Anna; Yamada Kyosuke; Auersperg Nelly; Liu Jinsong; Smith-McCune Karen; Lu Karen H; Fishman David; Gray Joe W; Mills Gordon B
The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers.
Nature medicine 2004;10(11):1251-6.
-
2004: Rosen Daniel G; Wang Lin; Jain Ajay N; Lu Karen H; Luo Robert Z; Yu Yinhua; Liu Jinsong; Bast Robert C
Expression of the tumor suppressor gene ARHI in epithelial ovarian cancer is associated with increased expression of p21WAF1/CIP1 and prolonged progression-free survival.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(19):6559-66.
-
2004: Slomovitz Brian M; Broaddus Russell R; Schmandt Rosemarie; Wu Weiguo; Oh Jonathan C; Ramondetta Lois M; Burke Thomas W; Gershenson David M; Lu Karen H
Expression of imatinib mesylate-targeted kinases in endometrial carcinoma.
Gynecologic oncology 2004;95(1):32-6.
-
2004: Soliman Pamela T; Slomovitz Brian M; Broaddus Russell R; Sun Charlotte C; Oh Jonathan C; Eifel Patricia J; Gershenson David M; Lu Karen H
Synchronous primary cancers of the endometrium and ovary: a single institution review of 84 cases.
Gynecologic oncology 2004;94(2):456-62.
-
2004: Slomovitz Brian M; Sun Charlotte C; Ramirez Pedro T; Bodurka Diane C; Diaz Paul; Lu Karen H
Does tamoxifen use affect prognosis in breast cancer patients who develop endometrial cancer?
Obstetrics and gynecology 2004;104(2):255-60.
-
2004: Slomovitz Brian M; Broaddus Russell R; Burke Thomas W; Sneige Nour; Soliman Pamela T; Wu Weiguo; Sun Charlotte C; Munsell Mark F; Gershenson David M; Lu Karen H
Her-2/neu overexpression and amplification in uterine papillary serous carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(15):3126-32.
-
2004: Broaddus Russell R; Lynch Patrick M; Lu Karen H; Luthra Raja; Michelson Sara J
Unusual tumors associated with the hereditary nonpolyposis colorectal cancer syndrome.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2004;17(8):981-9.
-
2004: Lu Karen H; Patterson Andrea P; Wang Lin; Marquez Rebecca T; Atkinson Edward N; Baggerly Keith A; Ramoth Lance R; Rosen Daniel G; Liu Jinsong; Hellstrom Ingegerd; Smith David; Hartmann Lynn; Fishman David; Berchuck Andrew; Schmandt Rosemarie; Whitaker Regina; Gershenson David M; Mills Gordon B; Bast Robert C
Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(10):3291-300.
-
2004: Oh Jonathan C; Wu Weiguo; Tortolero-Luna Guillermo; Broaddus Russell; Gershenson David M; Burke Thomas W; Schmandt Rosemarie; Lu Karen H
Increased plasma levels of insulin-like growth factor 2 and insulin-like growth factor binding protein 3 are associated with endometrial cancer risk.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2004;13(5):748-52.
-
2003: Slomovitz Brian M; Burke Thomas W; Eifel Patricia J; Ramondetta Lois M; Silva Elvio G; Jhingran Anuja; Oh Jonathan C; Atkinson E Neely; Broaddus Russell R; Gershenson David M; Lu Karen H
Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases.
Gynecologic oncology 2003;91(3):463-9.
-
2003: Wu Weiguo; Slomovitz Brian M; Celestino Joseph; Chung Linda; Thornton Angela; Lu Karen H
Coordinate expression of Cdc25B and ER-alpha is frequent in low-grade endometrioid endometrial carcinoma but uncommon in high-grade endometrioid and nonendometrioid carcinomas.
Cancer research 2003;63(19):6195-9.
-
2003: Schmandt Rosemarie E; Broaddus Russell; Lu Karen H; Shvartsman Hyun; Thornton Angela; Malpica Anais; Sun Charlotte; Bodurka Diane C; Gershenson David M
Expression of c-ABL, c-KIT, and platelet-derived growth factor receptor-beta in ovarian serous carcinoma and normal ovarian surface epithelium.
Cancer 2003;98(4):758-64.
-
2003: Shvartsman Hyun S; Lu Karen H; Lee John; Lillie Jim; Deavers Michael T; Clifford Stephanie; Wolf Judith K; Mills Gordon B; Bast Robert C; Gershenson David M; Schmandt Rosemarie
Overexpression of kallikrein 10 in epithelial ovarian carcinomas.
Gynecologic oncology 2003;90(1):44-50.
-
2003: Lee Christine M; Shvartsman Hyun; Deavers Michael T; Wang Shao-Chun; Xia Weiya; Schmandt Rosemarie; Bodurka Diane C; Atkinson E Neely; Malpica Anais; Gershenson David M; Hung Mien-Chie; Lu Karen H
beta-catenin nuclear localization is associated with grade in ovarian serous carcinoma.
Gynecologic oncology 2003;88(3):363-8.
-
2000: Lu K H; Garber J E; Cramer D W; Welch W R; Niloff J; Schrag D; Berkowitz R S; Muto M G
Occult ovarian tumors in women with BRCA1 or BRCA2 mutations undergoing prophylactic oophorectomy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(14):2728-32.
Sign-in to see more